Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma, Kaposi 1Prostate Cancer Recurrent 1Ovarian Neoplasms 1

Interventions

Nivolumab 5Specimen Handling 3Magnetic Resonance Spectroscopy 3pomalidomide 2pembrolizumab 2liposomal doxorubicin 2Propranolol 2lenvatinib 1ixazomib 1cabozantinib 1abemaciclib 1Paclitaxel 1Nelfinavir 1Ipilimumab 1Everolimus 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Kaposi × Nelfinavir × 1 year × Clear all
NCT03077451 2025-12-17

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Completed
36 enrolled 13 charts
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡